Sachin S Bhagwat (Sachin Bhagwat)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Multidrug Resistant

Helicobacter Pylori

Pseudomonas Aeruginosa

Top Venues

Xenobiotica; the fate of foreign compounds in biological systems

The Journal of antimicrobial chemotherapy

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

David P Nicolau, Sachin S Bhagwat, Kamilia Abdelraouf
Comment on: An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 76 (12) (2021)
Isabel Barceló, Gabriel Cabot, Snehal Palwe, Prashant Joshi, Swapna Takalkar, Hariharan Periasamy, Sara Cortés-Lara, Laura Zamorano, Irina Sánchez-Diener, Bartolome Moya, Sachin S Bhagwat, Mahesh Patel, Antonio Oliver
In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy. The Journal of antimicrobial chemotherapy 76 (10) (2021)
Rajesh Chavan, Vineet Zope, Nilesh Chavan, Javeed Shaikh, Kiran R Patil, Ravindra Yeole, Sachin S Bhagwat, Mahesh Patel
Assessment of in vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes. Xenobiotica; the fate of foreign compounds in biological systems 50 (10) (2020)
Rajesh Chavan, Vineet Zope, Nilesh Chavan, Kiran R Patil, Ravindra Yeole, Sachin S Bhagwat, Mahesh Patel
Assessment of the in vitro cytochrome P450 (CYP) inhibition potential of nafithromycin, a next generation lactone ketolide antibiotic. Xenobiotica; the fate of foreign compounds in biological systems 51 (3) (2020)
Sachin S Bhagwat, Manohar Nandanwar, Atul Kansagara, Anusuya Patel, Swapna Takalkar, Rajesh Chavan, Hariharan Periasamy, Ravindra Yeole, Prasad K Deshpande, Satish Bhavsar, Ashima Bhatia, Jaishid Ahdal, Rishi Jain, Mahesh Patel
Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence. Drug design, development and therapy 13 (2019)